Thank you to all those who have taken the Avertus survey. The response rate has been excellent, but we would like to give everyone a chance to respond. Accordingly, the deadline has been extended until Friday, February 7, 2014. Your responses and insights are critical for the early development of a new medical device that can improve the lives of millions of people affected by epilepsy.
_________________________________________________________________
Avertus Epilepsy Technologies Inc. is a new business formed to develop a new promising technology - a seizure monitoring and detection device for home use. Avertus in partnership with researchers at the University of Toronto are the development team working on a breakthrough system for the management and treatment of epilepsy.
The company is asking for those with epilepsy OR those who care for a loved one with epilepsy, to complete a short survey that will help us:
1. Determine the interest level of the technology underdevelopment;
2. Identify the critical features of the technology that will help guide its development and;
3. Develop a better understanding of the needs of the epilepsy community.
The survey is voluntary. The insights and opinions will be used to assist the research team in guiding the development of this new technology.
The survey will take you approximately 15-20 minutes and your responses are completely confidential and anonymous.
SURVEY LINK: http://fluidsurveys.com/s/epilepsy_survey/
